Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nuo Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $5.20M, up 166.6% year over year. For fiscal 2025 it was $3.31M, up 142.7% from the year before. Over ten years it grew -8.2% a year on average. The highest annual figure on record is $11.57M in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.31M | +142.7% |
| FY2024 | Dec 31, 2024 | $1.37M | +124.3% |
| FY2023 | Dec 31, 2023 | $608.53K | +442.1% |
| FY2022 | Dec 31, 2022 | $112.25K | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $146.18K | -89.3% |
| FY2018 | Dec 31, 2018 | $1.37M | +90.1% |
| FY2017 | Dec 31, 2017 | $721.05K | -93.7% |
| FY2015 | Dec 31, 2015 | $11.51M | +48.3% |
| FY2014 | Dec 31, 2014 | $7.76M | -32.9% |
| FY2013 | Dec 31, 2013 | $11.57M | +9.5% |
| FY2012 | Dec 31, 2012 | $10.56M | +45.8% |
| FY2011 | Dec 31, 2011 | $7.25M | +85.3% |
| FY2010 | Dec 31, 2010 | $3.91M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.77M | +152.6% |
| Q1 FY2026 | Mar 31, 2026 | $1.30M | +168.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.10M | +177.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.03M | +178.2% |
| Q2 FY2025 | Jun 30, 2025 | $700.20K | +92.0% |
| Q1 FY2025 | Mar 31, 2025 | $484.38K | +106.5% |
| Q4 FY2024 | Dec 31, 2024 | $394.87K | +100.4% |
| Q3 FY2024 | Sep 30, 2024 | $370.95K | +59.7% |
| Q2 FY2024 | Jun 30, 2024 | $364.77K | +208.7% |
| Q1 FY2024 | Mar 31, 2024 | $234.58K | +283.9% |
| Q4 FY2023 | Dec 31, 2023 | $197.02K | +166.2% |
| Q3 FY2023 | Sep 30, 2023 | $232.24K | +507.2% |
| Q2 FY2023 | Jun 30, 2023 | $118.17K | – |
| Q1 FY2023 | Mar 31, 2023 | $61.10K | – |
| Q4 FY2022 | Dec 31, 2022 | $74.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $38.25K | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | -100.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $0 | -100.0% |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.90K | -99.4% |
| Q3 FY2019 | Sep 30, 2019 | $57.88K | -77.8% |
| Q2 FY2019 | Jun 30, 2019 | $44.17K | -68.1% |
| Q1 FY2019 | Mar 31, 2019 | $39.23K | -75.5% |
| Q4 FY2018 | Dec 31, 2018 | $812.06K | +311.2% |
| Q3 FY2018 | Sep 30, 2018 | $260.28K | +60.5% |
| Q2 FY2018 | Jun 30, 2018 | $138.31K | -26.7% |
| Q1 FY2018 | Mar 31, 2018 | $159.94K | -7.4% |
| Q4 FY2017 | Dec 31, 2017 | $197.51K | +11.7% |
| Q3 FY2017 | Sep 30, 2017 | $162.20K | – |
| Q2 FY2017 | Jun 30, 2017 | $188.60K | – |
| Q1 FY2017 | Mar 31, 2017 | $172.74K | – |
| Q3 FY2016 | Sep 30, 2016 | $176.77K | – |
See a number that looks wrong?